fernando fervenza(@fervenzafernan1) 's Twitter Profileg
fernando fervenza

@fervenzafernan1

MD, PhD. consultant nephrologist. Mayo Clinic, Rochester, MN

ID:4839185056

calendar_today23-01-2016 17:14:39

2,3K Tweets

3,6K Followers

366 Following

Mayo Clinic Nephrology(@MayoClinicNeph) 's Twitter Profile Photo

Impact of glucocorticoid dose on complete response, serious infections, mortality during the initial therapy of lupus nephritis. fernando fervenza Alí Duarte, MD pubmed.ncbi.nlm.nih.gov/38766897/

account_circle
Kenar Jhaveri(@kdjhaveri) 's Twitter Profile Photo

Anti Nephrin Podocytopathy-- Time for some name changing-- its not MINIMAL change anymore.. Dusting on the wall was always there Astrid Weins

account_circle
Vincent Rajkumar(@VincentRK) 's Twitter Profile Photo

US healthcare is in many ways the best in the world. We have all the new drugs, tech, facilities, and expertise to deliver the most complex care when it’s needed.

But we need to do better. Racial and economic disparities are vast. Lots of bureaucracy. And it’s way too expensive.

account_circle
Andreas Kronbichler(@AKronbichler) 's Twitter Profile Photo

The second Austrian Mayo Clinic meeting is happening in 18 days in the 'Mozart' city Salzburg. It is not too late to register for this event: mayoclinic.congressinfo.eu
We are looking forward to two days of networking and discussions.

The second Austrian Mayo Clinic meeting is happening in 18 days in the 'Mozart' city Salzburg. It is not too late to register for this event: mayoclinic.congressinfo.eu We are looking forward to two days of networking and discussions.
account_circle
fernando fervenza(@fervenzafernan1) 's Twitter Profile Photo

Have you been diagnosed with Lupus Nephritis? You may be eligible for a clinical trial to study the treatment of class III, IV, & V Lupus Nephritis using a novel therapy at Mayo Clinic, Rochester, MN. For more information contact: [email protected] [email protected]

Have you been diagnosed with Lupus Nephritis? You may be eligible for a clinical trial to study the treatment of class III, IV, & V Lupus Nephritis using a novel therapy at Mayo Clinic, Rochester, MN. For more information contact: Geroux.nicholas@mayo.edu Bendtsen.Corbyn@mayo.edu
account_circle
Mayo Clinic Studies(@MayoStudies) 's Twitter Profile Photo

Do you have proliferative glomerulonephritis with monoclonal immune deposits (PGNMID)? You may be eligible for a clinical trial to study the treatment of PGNMID using a novel therapy. For more information, please visit mayocl.in/4c3AqUf

Do you have proliferative glomerulonephritis with monoclonal immune deposits (PGNMID)? You may be eligible for a clinical trial to study the treatment of PGNMID using a novel therapy. For more information, please visit mayocl.in/4c3AqUf
account_circle
Sanjeev Sethi(@SethiRenalPath) 's Twitter Profile Photo

Kidney International Université de Poitiers CHU de Poitiers CHU de Limoges Mayo Clinic Mayo ClinicPath I’m really glad to see this study. Almost 12 years have passed since we first reported on ApoA4 amyloid.
Medullary amyloidosis associated with apolipoprotein A-IV deposition - Kidney International kidney-international.org/article/S0085-…

account_circle
Wladimir Mietek Szpirt(@WLASZ) 's Twitter Profile Photo

As usual elegant presentation on ILD in AVV by Mayo pulmonologist expert Ulrich Specks. At least in DK we would like to have such expertise for our disposal! !

As usual elegant presentation on ILD in AVV by Mayo pulmonologist expert Ulrich Specks. At least in DK we would like to have such expertise for our disposal! #vasculitisBCN2024 !
account_circle
Marta Casal Moura(@martacasalmoura) 's Twitter Profile Photo

In 166 patients with AAV-GN and eGFR <15mL/min/1.73m2, lower chronicity grades on kidney biopsy were predictors of dialysis discontinuation and kidney failure recovery regardless the use of PLEX particularly in PR3-ANCA, GPA, and SCr < 5.7 mg/dL fernando fervenza Sanjeev Sethi

account_circle